Myocardial Stress Perfusion Imaging With Dual Source CT
Study Details
Study Description
Brief Summary
The investigators propose a novel technique using dual source multidetector computed tomography (DSCT) where information on both coronary anatomy and myocardial perfusion is obtained in a single scan. The investigators hypothesize that a coronary CTA protocol can be devised to obtain resting myocardial perfusion, myocardial perfusion after stress, and coronary anatomy. Hence, one diagnostic test will be able to detect the presence of coronary plaque as well as assess the functional significance of a stenosis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Adenosine Stress Dual-source CTP A multiphase adenosine Stress Dual-source stress perfusion computed tomography imaging test, as described above, will be performed in all patients. |
Other: Adenosine Stress Dual-source CTP
Adenosine- continuous infusion at 140mcg/ kg/ min for 2.5 min; Iopamidol (IV contrast)- total dose of 150cc; Siemens SOMATOM Definition CT scanner (CT scan radiation) - effective radiation dose of approximately 13mSv (tube voltage 120kV, tube current 340mAs for one retrospectively gated cardiac CT with tube current modulation and two prospectively gated cardiac CTs on a Dual Source scanner)
This is an observational trial, and all patients will undergo the Adenosine Stress Dual-source CTP procedure.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Per-Vessel Sensitivity of CTP in the Detection of Myocardial Perfusion Defects During Pharmacological Stress as Compared to Invasive Angiography. [18 months]
The gold standard for abnormality by CTP is defined as a focal stenosis of >50% at quantitative analysis of invasive coronary angiography images, when performed.
- Per-Vessel Specificity of CTP in the Detection of Myocardial Perfusion Defects During Pharmacological Stress as Compared to Invasive Angiography. [18 months]
The gold standard for abnormality by CTP is defined as stenosis of 50% or more at quantitative analysis of invasive coronary angiography images, when performed.
Secondary Outcome Measures
- Per-Patient Correlation Between CTP and SPECT at Stress. [18 months]
Pearson Correlation between research interpretation of CTP images and SPECT images, both performed during stress.
- Per-Patient Correlation Between CTP and SPECT at Rest. [18 months]
Pearson Correlation performed on myocardial abnormalities on CTP and SPECT images, obtained at rest.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
A prior adenosine or exercise stress SPECT exam with high likelihood of being referred to the cardiac catheterization laboratory for invasive angiogram
-
Age > 40 years old
-
Able to comprehend and sign the consent form.
Exclusion Criteria:
-
Acute coronary syndromes (unstable angina, non-ST elevation myocardial infarction, ST elevation myocardial infarction)
-
Unstable clinical conditions (i.e. hemodynamic instability, arrhythmias)
-
Premenopausal women who have a positive pregnancy test.
-
Serum Creatinine level ≥1.5 mg/dl as an indicator of renal insufficiency.
-
Known allergy to iodinated contrast agents
-
Atrial fibrillation
-
Asthma
-
Critical aortic stenosis
-
Systolic blood pressure < 90 mmHg
-
Advanced heart block
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Massachusetts General Hospital | Boston | Massachusetts | United States | 02114 |
Sponsors and Collaborators
- Massachusetts General Hospital
- Astellas Pharma Inc
Investigators
- Principal Investigator: Brian B Ghoshhajra, MD, Massachusetts General Hospital
- Study Director: Ricardo C Cury, MD, Massachusetts General Hospital, Baptist Hospital, Miami
Study Documents (Full-Text)
None provided.More Information
Publications
- Hulten EA, Bittencourt MS, Ghoshhajra B, Blankstein R. Stress CT perfusion: coupling coronary anatomy with physiology. J Nucl Cardiol. 2012 Jun;19(3):588-600. doi: 10.1007/s12350-012-9546-5. Review.
- Techasith T, Cury RC. Stress myocardial CT perfusion: an update and future perspective. JACC Cardiovasc Imaging. 2011 Aug;4(8):905-16. doi: 10.1016/j.jcmg.2011.04.017. Review.
- DSCTSTRESS
Study Results
Participant Flow
Recruitment Details | Recruitment Period: 3/3/2008 - 7/1/2009 |
---|---|
Pre-assignment Detail |
Arm/Group Title | Myocardial Stress CT Perfusion Imaging |
---|---|
Arm/Group Description | Patients who will undergo myocardial stress CT perfusion imaging. Adenosine- continuous infusion at 140mcg/ kg/ min for 2.5 min; Iopamidol (IV contrast)- total dose of 150cc; Siemens SOMATOM Definition CT scanner (CT scan radiation) - effective radiation dose of approximately 13mSv (tube voltage 120kV, tube current 340mAs for one retrospectively gated cardiac CT with tube current modulation and two prospectively gated cardiac CTs on a Dual Source scanner) |
Period Title: Overall Study | |
STARTED | 50 |
COMPLETED | 50 |
NOT COMPLETED | 0 |
Baseline Characteristics
Arm/Group Title | Myocardial Stress CT Perfusion Imaging |
---|---|
Arm/Group Description | Patients who will undergo myocardial stress CT perfusion imaging. |
Overall Participants | 50 |
Age (Count of Participants) | |
<=18 years |
0
0%
|
Between 18 and 65 years |
32
64%
|
>=65 years |
18
36%
|
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
62.3
(10.4)
|
Sex: Female, Male (Count of Participants) | |
Female |
9
18%
|
Male |
41
82%
|
Region of Enrollment (participants) [Number] | |
United States |
50
100%
|
Outcome Measures
Title | Per-Vessel Sensitivity of CTP in the Detection of Myocardial Perfusion Defects During Pharmacological Stress as Compared to Invasive Angiography. |
---|---|
Description | The gold standard for abnormality by CTP is defined as a focal stenosis of >50% at quantitative analysis of invasive coronary angiography images, when performed. |
Time Frame | 18 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Myocardial Stress CT Perfusion Imaging |
---|---|
Arm/Group Description | Patients who will undergo myocardial stress CT perfusion imaging. |
Measure Participants | 50 |
Number (95% Confidence Interval) [percentage of participants] |
79
158%
|
Title | Per-Patient Correlation Between CTP and SPECT at Stress. |
---|---|
Description | Pearson Correlation between research interpretation of CTP images and SPECT images, both performed during stress. |
Time Frame | 18 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Myocardial Stress CT Perfusion Imaging |
---|---|
Arm/Group Description | Patients who will undergo myocardial stress CT perfusion imaging. |
Measure Participants | 50 |
Number [correlation coefficient] |
0.60
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Myocardial Stress CT Perfusion Imaging |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | <0.0001 |
Comments | ||
Method | Pearson Correlation | |
Comments |
Title | Per-Vessel Specificity of CTP in the Detection of Myocardial Perfusion Defects During Pharmacological Stress as Compared to Invasive Angiography. |
---|---|
Description | The gold standard for abnormality by CTP is defined as stenosis of 50% or more at quantitative analysis of invasive coronary angiography images, when performed. |
Time Frame | 18 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Myocardial Stress CT Perfusion Imaging |
---|---|
Arm/Group Description | Patients who will undergo myocardial stress CT perfusion imaging. |
Measure Participants | 50 |
Number (95% Confidence Interval) [percentage of participants] |
80
160%
|
Title | Per-Patient Correlation Between CTP and SPECT at Rest. |
---|---|
Description | Pearson Correlation performed on myocardial abnormalities on CTP and SPECT images, obtained at rest. |
Time Frame | 18 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Myocardial Stress CT Perfusion Imaging |
---|---|
Arm/Group Description | Patients who will undergo myocardial stress CT perfusion imaging. |
Measure Participants | 50 |
Number [correlation coefficient] |
0.76
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Myocardial Stress CT Perfusion Imaging |
---|---|---|
Comments | Pearson Correlation | |
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | <0.0001 |
Comments | ||
Method | Pearson Correlation | |
Comments |
Adverse Events
Time Frame | 1 day | |
---|---|---|
Adverse Event Reporting Description | To assure subject's safety, the study physician will monitor the safety of the subject. Heart rate and blood pressure will be measured immediately prior and 2 and 5 minutes after the administration of adenosine. ECG and heart rate will be continuously monitored during scanning. If adverse events occur the exam will immediately be stopped. | |
Arm/Group Title | Myocardial Stress CT Perfusion Imaging | |
Arm/Group Description | Patients who will undergo myocardial stress CT perfusion imaging. | |
All Cause Mortality |
||
Myocardial Stress CT Perfusion Imaging | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
Myocardial Stress CT Perfusion Imaging | ||
Affected / at Risk (%) | # Events | |
Total | 0/50 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Myocardial Stress CT Perfusion Imaging | ||
Affected / at Risk (%) | # Events | |
Total | 0/50 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
Results Point of Contact
Name/Title | Dr. Brian B. Ghoshhajra |
---|---|
Organization | Massachusetts General Hospital |
Phone | 617-726-3745 |
bghoshhajra@partners.org |
- DSCTSTRESS